New research report 20th November 2015, page-19

I like this bit -
"Our model suggests Anteo Diagnostics is currently worth AUD 170-230 million, which compares
to the market capitalisation of AUD 76.3 million. On a per share basis, using the number of shares
in issue of 857.3 million we derive a value of AUD 0.20-0.27 per share. This is based on the
current value of its Mix&Go platform and the further roll out of its current products in both North
America and Europe via the acquisition of DIAsource. The AUD 0.20-0.27 per share value is not a price target but a fair value for the stock today."